Efficacy of Navigation for Disparities and Untimely Radiation ThErapy: The ENDURE Study
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/8/2019 |
| Start Date: | April 8, 2019 |
| End Date: | November 1, 2020 |
| Contact: | Evan Graboyes, MD |
| Email: | graboyes@musc.edu |
| Phone: | (843) 792-0719 |
This study will evaluate whether a new patient navigation intervention can decrease delays
starting post-operative radiation therapy after surgery for white and African-American head
and neck cancer patients.
starting post-operative radiation therapy after surgery for white and African-American head
and neck cancer patients.
The investigators will perform a single site, prospective, single-arm clinical trial of
patient navigation (PN) for patients with HNC undergoing surgery and PORT (n=45; African
American n=15; white n=30). The trial will provide preliminary data on the effects of patient
navigation on delays and racial disparities starting postoperative radiation treatment
(PORT). The investigators hypothesize that PN will improve the timeliness of PORT for white
and African American head and neck cancer patients and decrease the difference in delays
between the two populations.
patient navigation (PN) for patients with HNC undergoing surgery and PORT (n=45; African
American n=15; white n=30). The trial will provide preliminary data on the effects of patient
navigation on delays and racial disparities starting postoperative radiation treatment
(PORT). The investigators hypothesize that PN will improve the timeliness of PORT for white
and African American head and neck cancer patients and decrease the difference in delays
between the two populations.
Inclusion Criteria
- Age >/= 18
- Self-identified white or African American race
- Squamous cell carcinoma of the upper aerodigestive tract (oral cavity, oropharynx,
hypopharynx, larynx)
- American Joint Committee on Cancer (AJCC) stages I-IV
- Plan for curative intent surgery at MUSC followed by adjuvant radiation with or
without chemotherapy
Exclusion criteria
- Hispanic ethnicity
- Cognitive impairment preventing completion of interviews, as judged by their oncology
provider
We found this trial at
1
site
171 Ashley Avenue
Charleston, South Carolina 29425
Charleston, South Carolina 29425
843-792-1414
Phone: 843-792-0719
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
Click here to add this to my saved trials
